Greenwood Capital Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $844K | Buy |
+4,547
| New | +$844K | 0.11% | 149 |
|
|
2022
Q2 | – | Sell |
-708
| Closed | -$115K | – | 205 |
|
|
2022
Q1 | $115K | Sell |
708
-13,342
| -95% | -$2.17M | 0.03% | 149 |
|
|
2021
Q4 | $1.9M | Buy |
14,050
+1,808
| +15% | +$245K | 0.27% | 70 |
|
|
2021
Q3 | $1.32M | Buy |
12,242
+1,708
| +16% | +$184K | 0.2% | 91 |
|
|
2021
Q2 | $1.19M | Buy |
10,534
+2,211
| +27% | +$249K | 0.18% | 96 |
|
|
2021
Q1 | $901K | Buy |
8,323
+2,884
| +53% | +$312K | 0.14% | 119 |
|
|
2020
Q4 | $582K | Buy |
5,439
+1,791
| +49% | +$192K | 0.1% | 152 |
|
|
2020
Q3 | $320K | Buy |
+3,648
| New | +$320K | 0.06% | 160 |
|
|
2019
Q3 | – | Sell |
-42,005
| Closed | -$3.06M | – | 171 |
|
|
2019
Q2 | $3.06M | Buy |
+42,005
| New | +$3.06M | 0.77% | 49 |
|
|
2019
Q1 | – | Sell |
-4,400
| Closed | -$406K | – | 168 |
|
|
2018
Q4 | $406K | Buy |
+4,400
| New | +$406K | 0.11% | 111 |
|
|
2015
Q3 | – | Sell |
-38,569
| Closed | -$2.59M | – | 152 |
|
|
2015
Q2 | $2.59M | Sell |
38,569
-5,145
| -12% | -$346K | 0.78% | 53 |
|
|
2015
Q1 | $2.56M | Buy |
43,714
+494
| +1% | +$28.9K | 0.73% | 64 |
|
|
2014
Q4 | $2.83M | Buy |
43,220
+371
| +0.9% | +$24.3K | 0.82% | 52 |
|
|
2014
Q3 | $2.48M | Buy |
+42,849
| New | +$2.48M | 0.76% | 57 |
|